Rm. Quinlivan et al., CARDIAC-FUNCTION, METABOLISM AND PERFUSION IN DUCHENNE AND BECKER MUSCULAR-DYSTROPHY, Neuromuscular disorders, 6(4), 1996, pp. 237-246
We studied 23 DMD and eight BMD patients using cardiac echo, 24 h ECG
and positron emission tomography (PET) with the radiotracers N-13 ammo
nia and F-18 fluorine deoxyglucose. The ECG was abnormal in 23 cases w
ith alterations in the PR and/or QT intervals, abnormal Q waves in the
lateral leads and ST segment depression. Twenty-four hour ECG showed
that patients were more likely to produce premature ventricular ectopi
c beats with advancing age and 17 patients had paroxysmal ST segment d
epression. LV function was normal or mildly reduced in 24 cardiac echo
es. PET studies were visibly abnormal in 15 patients. Regional perfusi
on defects involving the apex, lateral or anterior left ventricular wa
lls were present, nine cases demonstrated a corresponding increase in
glucose metabolism. Three out of 15 demonstrated matched perfusion/met
abolism defects. One BMD had severe LV dilation with globally poor per
fusion and metabolism. The abnormalites seen with PET were confirmed w
ith both quantitative and semi-quantitative analysis of radioactive co
unts. Similar results were obtained for both DMD and BMD, where both g
roups demonstrated significant regional perfusion/metabolism mismatche
s. We have shown a reduced uptake of N-13 ammonia which is indicative
of a reduction in myocardial perfusion. The use of N-13 ammonia to mea
sure perfusion has been validated in animal studies. PET with either N
-13 ammonia- or oxygen labelled water can be used to measure myocardia
l perfusion. We chose N-13 ammonia as this was most readily available
to us.